Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2019 08:00 ET | Source: Chimerix, Inc.

Chimerix Announces First Quarter 2019 Financial Results and Strategy Update

– Reports Positive Top-line Survival Data from Pivotal Mouse Study as Key Milestone on Path to Smallpox Regulatory Submission – – Plan to Focus on Execution of Smallpox Program, Halting All Other...
May 02, 2019 16:01 ET | Source: Chimerix, Inc.

Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019

DURHAM, N.C., May 02, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced...
April 08, 2019 17:00 ET | Source: Chimerix, Inc.

Chimerix Announces Management Updates

DURHAM, N.C., April 08, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announces the appointment of...
March 05, 2019 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces Fourth Quarter and Full Year 2018 Financial Results

– Reports Positive Preliminary Top-line Data from Second Rabbitpox Study – – Type C Meeting Requested with FDA Regarding Virologic Endpoint – – Conference Call at 8:30 a.m. ET Today – ...
March 04, 2019 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at Cowen and Company 39th Annual Health Care Conference

DURHAM, N.C., March 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that...
February 26, 2019 08:00 ET | Source: Chimerix, Inc.

Chimerix to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019

DURHAM, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced...
February 22, 2019 08:00 ET | Source: Chimerix, Inc.

Chimerix Presents Results from Post-hoc Analysis of Phase 3 Study

Decreased HHV-6 Reactivation Observed Among Oral Brincidofovir Allogeneic Hematopoietic Cell Transplantation Recipients Results to be Presented at Transplantation and Cellular Therapy Meetings of...
February 06, 2019 08:00 ET | Source: Chimerix, Inc.

Chimerix Announces Management Transition

M. Michelle Berrey to Step Down as Chief Executive Officer DURHAM, N.C., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to...
January 04, 2019 07:30 ET | Source: Chimerix, Inc.

Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that M....
November 08, 2018 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces Third Quarter 2018 Financial Results

- Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address...